ScholarIQanswers from OpenAlex

Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation

PaperCitations, authors & open-access status

Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation have?

ScholarIQcitation count

Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation has 33 citations in the OpenAlex counts ScholarIQ stores.

When was Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation published?

ScholarIQyear

Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation has 2022 year in the ScholarIQ index.

What is the open-access status of Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation?

ScholarIQoa status

Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation has gold oa status in the ScholarIQ index.

What is the DOI of Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation?

ScholarIQdoi

The DOI for Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation is on the source record.

What is the PMID of Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation?

ScholarIQpmid

The PMID for Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation is on the source record.

What is the OpenAlex record for Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation?

ScholarIQopenalex

The OpenAlex for Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial